Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
55.2M
-
Number of holders
-
130
-
Total 13F shares, excl. options
-
30.4M
-
Shares change
-
-40.3K
-
Total reported value, excl. options
-
$423M
-
Value change
-
-$7.29M
-
Number of buys
-
67
-
Number of sells
-
-57
-
Price
-
$13.95
Significant Holders of Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) as of Q4 2019
152 filings reported holding VYGR - Voyager Therapeutics, Inc. - Common Stock, $0.001 par value as of Q4 2019.
Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) has 130 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 30.4M shares
of 55.2M outstanding shares and own 55.02% of the company stock.
Largest 10 shareholders include TRV GP III, LLC (6.39M shares), Bellevue Group AG (2.7M shares), BlackRock Inc. (2.12M shares), VANGUARD GROUP INC (2.09M shares), ARMISTICE CAPITAL, LLC (1.62M shares), STATE STREET CORP (1.33M shares), RENAISSANCE TECHNOLOGIES LLC (1.25M shares), Casdin Capital, LLC (1.1M shares), FEDERATED HERMES, INC. (1.03M shares), and Clearbridge Investments, LLC (1.01M shares).
This table shows the top 130 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.